Medical Injection Molding Machines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented, By Material (Polypropylene, Polyethylene, Thermoplastic Elastomer, Cyclic Olefin Copolymer, Acrylonitrile Butadiene Styrene, Others), By Application (Surgery, Pharma, Diagnostics, Medical Equipment, Healthcare, Cosmetics), By Machine Type (Standard Injection Molding Machine, Multi-component Injection Molding Machine, LSR Injection Molding Machine), By Region, By Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 3.03 Billion
CAGR (2026-2031)	4.95%
Fastest Growing Segment	Polyethylene
Largest Market	North America
Market Size (2031)	USD 4.05 Billion

Market Overview

The Global Medical Injection Molding Machines Market will grow from USD 3.03 Billion in 2025 to USD 4.05 Billion by 2031 at a 4.95% CAGR. Medical injection molding machines are specialized manufacturing systems engineered to produce high-precision, medical-grade plastic components under strict hygiene standards, often operating within ISO-certified cleanroom environments. The market is primarily driven by the escalating demand for single-use medical devices and consumables, necessitating high-volume, sterile production capabilities to mitigate cross-contamination risks in healthcare settings. Furthermore, the rising global prevalence of chronic diseases and an aging population require increasingly complex drug delivery systems, sustaining the need for advanced molding technologies that ensure biocompatibility and exact specifications.

Despite these growth factors, the market faces a significant challenge in the form of economic volatility and high capital investment costs, which can delay procurement decisions. This instability affects equipment shipment volumes as manufacturers adjust to shifting demand. According to the Plastics Industry Association, in 2025, injection molding shipments in North America rose by 30.0 percent in the third quarter compared to the previous quarter. Such fluctuations in capital equipment investment, often influenced by broader economic headwinds, represent a substantial impediment to the steady expansion of production capacity within the medical manufacturing sector.

Key Market Drivers

The rising demand for single-use medical devices and consumables serves as a primary catalyst for market expansion, fueled by stringent infection prevention protocols and the proliferation of self-administered drug delivery therapies. As healthcare providers prioritize sterile, disposable products to mitigate cross-contamination, molders are ramping up capacity for high-volume components such as prefilled syringes, auto-injectors, and diagnostic cartridges. This surge in consumption directly necessitates advanced manufacturing infrastructure to meet production targets. According to Gerresheimer AG, February 2025, in the 'Annual Report 2024', the Plastics & Devices Division generated EUR 1,141.3 million in revenue, achieving 8.0% organic growth specifically driven by the strong demand for drug delivery systems.

Simultaneously, the industry is undergoing a critical technological transition to high-precision all-electric molding systems, which are increasingly replacing hydraulic alternatives in medical manufacturing. These electric machines are indispensable for cleanroom operations due to their oil-free mechanisms, energy efficiency, and ability to mold intricate geometries with exacting repeatability. This shift is evident in the recent sales performance of major equipment suppliers who are capitalizing on the medical sector's requirements. According to Fanuc Corporation, February 2025, in the 'Consolidated Financial Results for the Nine Months Ended December 31, 2024', the Robomachine division recorded a 21.8% increase in net sales, supported by growth in Roboshot electric injection molding machine orders. Underscoring the scale of this global equipment demand, according to Haitian International, in 2025, the company reported a 23.4% increase in annual revenue to RMB 16.1 billion for the 2024 fiscal year.

Download Free Sample Report

Key Market Challenges

Economic volatility and high capital investment costs significantly impede the steady growth of the Global Medical Injection Molding Machines Market. Medical manufacturing requires expensive, high-precision equipment to meet strict regulatory standards, making procurement decisions highly sensitive to financial instability. When manufacturers face uncertain economic climates or elevated interest rates, they often postpone capital expenditures to conserve cash flow and mitigate financial risk. This reluctance to invest results in erratic order volumes for machinery suppliers, preventing the consistent scaling of production capabilities necessary to meet the rising demand for medical consumables.

This market instability is substantiated by recent industrial data highlighting severe fluctuations in equipment acquisition. According to the Plastics Industry Association, in the first quarter of 2025, shipments of injection molding machinery in North America declined by 21.8 percent compared to the previous quarter. This sharp downturn, preceding the recovery seen later in the year, demonstrates how economic headwinds cause immediate contractions in investment. Such unpredictability complicates long-term planning for medical device producers, as they must continuously adjust their capacity expansion strategies to align with shifting financial realities rather than long-term healthcare needs.

Key Market Trends

The integration of Industry 4.0 and smart manufacturing technologies is fundamentally reshaping production protocols within the medical sector, moving beyond simple machine operation to fully connected, intelligent ecosystems. Manufacturers are increasingly adopting predictive maintenance and real-time process monitoring systems to ensure the zero-defect quality required for critical medical components, thereby minimizing downtime and regulatory risks. This operational shift toward digitalized automation is essential for maintaining the stringent standards required for cleanroom environments while optimizing resource allocation. The demand for such advanced capabilities is evident in recent industrial performance metrics. According to Engel Group, May 2025, in the press release 'ENGEL expands market share amid global uncertainty', the company reported a turnover of approximately EUR 1.5 billion for the 2024/25 financial year, highlighting that it successfully expanded its market share through targeted innovations in automation and service despite a global decline in investment activity.

Simultaneously, the market is witnessing a distinct expansion in multi-component and multi-shot molding capabilities, driven by the need to produce complex, composite medical devices in a single manufacturing cycle. This trend is particularly prevalent in the fabrication of drug delivery systems and diagnostic tools, where soft-touch grips, seals, and rigid structural parts must be integrated without secondary assembly steps to reduce contamination risks. Equipment suppliers are actively expanding their portfolios to support these sophisticated multi-material applications through strategic acquisitions and technology enhancements. Underscoring this trend, according to Modern Plastics Canada, March 2025, in the article 'Husky Technologies Secures Key Tech to Expand Market Reach', Husky Technologies acquired the secondary injection unit and rotary platen technologies from MGS Healthcare Manufacturing to directly strengthen its provision of integrated multi-material solutions for the medical market.

Segmental Insights

The Polyethylene segment constitutes the fastest-growing category within the Global Medical Injection Molding Machines Market, primarily driven by the material's exceptional biocompatibility, chemical resistance, and durability. Medical device manufacturers are increasingly utilizing High-Density Polyethylene and Ultra-High Molecular Weight Polyethylene to produce critical components, ranging from orthopedic implants to pharmaceutical containers. This surge in demand is supported by the material's ability to meet rigorous safety standards, such as those enforced by the U.S. Food and Drug Administration (FDA), necessitating advanced molding machinery that ensures precise, contaminant-free production for high-volume healthcare applications.

Regional Insights

North America leads the Global Medical Injection Molding Machines Market, primarily driven by its extensive healthcare infrastructure and consistent demand for medical devices. The region hosts a large number of original equipment manufacturers that produce essential items like syringes and surgical implants. Furthermore, the U.S. Food and Drug Administration (FDA) mandates strict quality control measures, compelling manufacturers to invest in precise molding machinery to maintain compliance and safety. This regulatory environment, coupled with high healthcare expenditure, ensures the region remains the central hub for medical device production technology.

Recent Developments

• In November 2024, Wittmann Battenfeld demonstrated advanced capabilities in micro injection molding at the Compamed trade fair. The company collaborated with a Vienna-based partner to showcase the production of parts featuring nano-scale structures using a MicroPower 15/10 machine. This system utilized a specialized two-step screw-and-plunger injection unit to process thermally homogeneous melt with extreme precision. The presentation highlighted the ability to manufacture micro parts with complex surface details in short cycle times, opening new possibilities for miniaturized applications in the medical technology field, such as lab-on-a-chip devices and microfluidic components.
• In October 2024, Husky Technologies presented its integrated ICHOR system at the Fakuma trade fair, targeting the high-precision requirements of the medical device sector. The system was showcased producing blood collection tubes, demonstrating a comprehensive solution that combines the mold, hot runner, controller, and automation into a single platform. This launch emphasized the company's focus on reducing part variability and enhancing predictability for medical manufacturers. The technology was designed to support the production of various medical consumables, including pipette tips and other diagnostic devices, by streamlining the molding process and ensuring consistent quality.
• In July 2024, Sumitomo (SHI) Demag announced the expansion of its medical machine portfolio with a new configuration for the IntElect series. The company revealed a compact 180-ton all-electric machine equipped with a larger injection unit, designed to handle heavier shot weights for medical components. This development was aimed at increasing production efficiency for parts such as syringe plungers while minimizing the equipment's footprint. The system demonstrated the capability to mold high-density polyethylene parts with precise repeatability, addressing the sector's demand for high-volume, tight-tolerance manufacturing in cleanroom settings.
• In March 2024, Arburg introduced a novel medical in-mold labeling application, showcasing the potential for labeling centrifuge tubes directly during the injection molding process. This demonstration featured the electric Allrounder 520 A "Ultimate" machine, which is specifically engineered for cleanroom environments. The system produced 15-milliliter tubes using an eight-cavity mold, with labels precisely aligned and applied by a specialized adjustment head. By integrating the labeling step, the company highlighted a method to enhance process efficiency and traceability in medical manufacturing, eliminating the need for downstream printing or bonding operations.

Key Market Players

• Hillenbrand, Inc.
• WITTMANN Technology GmbH
• UBE Machinery Inc.
• KraussMaffei Group
• Japan Steel Works, Ltd.
• AMS Micromedical, LLC.
• Proto Labs, Inc.
• Sumitomo (SHI) Demag Plastics Machinery GmbH
• Milacron LLC
• ENGEL AUSTRIA GmbH

By Material	By Application	By Machine Type	By Region
Polypropylene Polyethylene Thermoplastic Elastomer Cyclic Olefin Copolymer Acrylonitrile Butadiene Styrene Others	Surgery Pharma Diagnostics Medical Equipment Healthcare Cosmetics	Standard Injection Molding Machine Multi-component Injection Molding Machine LSR Injection Molding Machine	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Medical Injection Molding Machines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Medical Injection Molding Machines Market, By Material:

• Polypropylene
• Polyethylene
• Thermoplastic Elastomer
• Cyclic Olefin Copolymer
• Acrylonitrile Butadiene Styrene
• Others

• Medical Injection Molding Machines Market, By Application:

• Surgery
• Pharma
• Diagnostics
• Medical Equipment
• Healthcare
• Cosmetics

• Medical Injection Molding Machines Market, By Machine Type:

• Standard Injection Molding Machine
• Multi-component Injection Molding Machine
• LSR Injection Molding Machine

• Medical Injection Molding Machines Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE